BIODESIX INC (BDSX)
US09075X1081 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 26.28M | 43.10M | 32.70M | 62.10M | 5.30M | |||
| Receivables | 7.68M | 5.10M | 3.70M | 15.30M | 5.30M | |||
| Other Current Assets | 5.72M | 5.20M | 7.20M | 8.70M | 2.10M | |||
| Total Current Assets | 39.68M | 53.30M | 43.60M | 86.10M | 12.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 29.61M | 8.80M | 4.20M | 3.20M | 2.10M | |||
| Goodwill | 15.03M | 15.00M | 15.00M | 15.00M | 11.60M | |||
| Intangibles | 7.91M | 9.80M | 11.60M | 13.30M | 15.10M | |||
| Other Non-Current Assets | 6.86M | 5.90M | 1.70M | 3.50M | 100.00K | |||
| Total Non-Current Assets | 59.41M | 39.60M | 32.50M | 35.00M | 28.90M | |||
| TOTAL ASSETS | 99.10M | 92.90M | 76.10M | 121.10M | 41.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 12.00M | |||
| Current Portion Of LT Debt. | 51.00K | 0.00 | 0.00 | 11.80M | 0.00 | |||
| Accrued Expenses | 5.09M | 7.40M | 4.90M | 4.70M | 1.90M | |||
| Accounts Payable | 2.93M | 1.70M | 1.70M | 9.00M | 1.70M | |||
| Other Current Liabilities | 25.35M | 13.70M | 22.40M | 6.60M | 6.90M | |||
| Total Current Liabilities | 33.42M | 22.80M | 29.00M | 32.10M | 22.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 35.23M | 25.00M | 10.00M | 15.90M | 23.80M | |||
| Other Non-Current Liabilities | 25.88M | 24.50M | 17.40M | 31.90M | 29.80M | |||
| Total Non-Current Liabilities | 61.10M | 49.50M | 27.40M | 47.80M | 53.60M | |||
| TOTAL LIABILITIES | 94.52M | 72.30M | 56.40M | 79.90M | 76.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -419.57M | -367.40M | -302.00M | -258.80M | -230.90M | |||
| Additional Paid In Capital | 424.05M | 387.90M | 321.70M | 300.00M | 2.30M | |||
| Common Shares | 96.00K | 100.00K | 0.00 | 0.00 | 194.00M | |||
| Shares Outstanding | 96.24M | 77.60M | 30.80M | 26.60M | 26.30M | |||
| Tangible Book Value per Share | -0.19 | -0.05 | -0.22 | 0.48 | -9.71 | |||
| Total Shareholders' Equity | 4.58M | 20.60M | 19.70M | 41.20M | -34.60M | |||
| TOTAL LIABILITIES AND EQUITY | 99.10M | 92.90M | 76.10M | 121.10M | 41.60M | |||
| Statistics | ||||||||
| Debt/Equity | 7.69 | 1.21 | 0.51 | 0.39 | -1.03 | |||
| Current Ratio | 1.19 | 2.34 | 1.50 | 2.68 | 0.56 | |||
| Return On Assets (ROA) | -52.62% | -70.45% | -56.71% | -25.89% | -73.87% | |||
| Return On Equity (ROE) | -1138.56% | -317.72% | -219.09% | -76.09% | N/A | |||
All data in USD